HBV-IN-47
HBV-IN-47 (compound 4a) is a capsid assembly regulator with inhibitory activity against hepatitis B virus (HBV) . HBV-IN-47 exhibits strong anti-HBV activity in HepAD38 cells with low toxicity (EC50=0.24 μM) . HBV-IN-47 can be used for the study of chronic hepatitis B (CHB) [1].
Product Specifications
UNSPSC
12352211
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hbv-in-47.html
Smiles
O=C(NC1=CC(F)=C(F)C(F)=C1)C2=CC(S(=O)(NC3CCCC3)=O)=CC4=C2OCCO4
Molecular Formula
C20H19F3N2O5S
Molecular Weight
456.44
References & Citations
[1]M Liang, et al. "Design, synthesis and anti-HBV activity study of novel HBV capsid assembly modulators." Bioorganic & Medicinal Chemistry Letters (2024) : 129913.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400994-500 1x 500 µL
TNF alpha (J2D10), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400040-500 1x 500 µL
CD35 / CR1 (E11), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941865-500 1x 500 µL
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1865R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040763-100 1x 100 µL
CD34 (HPCA1/763), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680096-100 1x 100 µL
Histone H1 (AE-4), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details